Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Bone Marrow Transplant. 2013 Feb 18;48(8):1056–1064. doi: 10.1038/bmt.2012.284

Table 7.

Outcomes by conditioning regimen subtype

Outcome event Non-myeloablative/RIC Myeloablative P-value
N eval. Prob (95% CI)a N eval. Prob (95% CI)
Transplant-related mortality 33 73
  @ 100days 9 (2-22) 23 (14-33) 0.0437
  @ 1 year 15 (6-30) 30 (20-41) 0.0742
  @ 3 years 19 (8-34) 30 (20-41) 0.1803
  @ 5 years 19 (8-34) 30 (20-41) 0.1803
Relapse
  @ 1 year 65 (46-79) 27 (17-37) 0.0001
  @ 3 years 69 (49-82) 43 (31-54) 0.011
  @ 5 years 69 (49-82) 47 (35-58) 0.036
Disease-free survival 33 73 P_overall=0.167
  @ 1 year 19 (8-34) 43 (31-54) 0.0097
  @ 3 years 13 (4-27) 27 (17-38) 0.0776
  @ 5 years 13 (4-27) 22 (13-33) 0.2175
Overall survival 35 96 P_overall=0.128
  @ 1 year 51 (33-67) 56 (45-65) 0.6248
  @ 3 years 16 (6-30) 34 (25-44) 0.026
  @ 5 years 16 (6-30) 25 (17-35) 0.2348

Abreviations: CI: confidence interval, RIC: reduced intensity conditioning